Cerenome subsidiary signs in-network deal with BCBSM for CNSide coverage
CNSide Diagnostics, a Cerenome subsidiary, signed an in-network provider agreement with Blue Cross Blue Shield of Michigan effective September 1, expanding CNSide® contracted coverage to about 158 million covered lives.